Cargando…

Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy

SIMPLE SUMMARY: Cancer stem cells are thought to cause a poor response to chemotherapies. The aim of our study was to explore the still unknown biology of hepatoblastoma cancer stem cells that are essential for tumorigenesis. With our investigations, we aimed to gain more insight into cancer stem ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee-Theilen, Mieun, Fadini, Delaine D., Hadhoud, Julia R., van Dongen, Fleur, Kroll, Gabriela, Rolle, Udo, Fiegel, Henning C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736435/
https://www.ncbi.nlm.nih.gov/pubmed/36497307
http://dx.doi.org/10.3390/cancers14235825
_version_ 1784847026409701376
author Lee-Theilen, Mieun
Fadini, Delaine D.
Hadhoud, Julia R.
van Dongen, Fleur
Kroll, Gabriela
Rolle, Udo
Fiegel, Henning C.
author_facet Lee-Theilen, Mieun
Fadini, Delaine D.
Hadhoud, Julia R.
van Dongen, Fleur
Kroll, Gabriela
Rolle, Udo
Fiegel, Henning C.
author_sort Lee-Theilen, Mieun
collection PubMed
description SIMPLE SUMMARY: Cancer stem cells are thought to cause a poor response to chemotherapies. The aim of our study was to explore the still unknown biology of hepatoblastoma cancer stem cells that are essential for tumorigenesis. With our investigations, we aimed to gain more insight into cancer stem cell characteristics and to provide directions for new therapeutic approaches to treat refractory hepatoblastoma. We showed that hepatoblastoma cancer stem cells express PD-L1, a factor which helps tumors escape immune attacks. Furthermore, we detected cancer stem cell progeny evolving from non-cancer stem cells. Finally, we revealed that another subset of cancer stem cells is induced during chemotherapy. Our findings give a possible explanation why chemotherapies fail in certain hepatoblastoma cases and why new therapeutic approaches should consider the plasticity of hepatoblastoma cancer stem cells. ABSTRACT: The biology of cancer stem cells (CSCs) of pediatric cancers, such as hepatoblastoma, is sparsely explored. This is mainly due to the very immature nature of these tumors, which complicates the distinction of CSCs from the other tumor cells. Previously, we identified a CSC population in hepatoblastoma cell lines expressing the CSC markers CD34 and CD90, cell surface Vimentin (csVimentin) and binding of OV-6. In this study, we detected the co-expression of the immune escape factor PD-L1 in the CSC population, whereas the other tumor cells remained negative. FACS data revealed that non-CSCs give rise to CSCs, reflecting plasticity of CSCs and non-CSCs in hepatoblastoma as seen in other tumors. When we treated cells with cisplatin and decitabine, a new CD34(+/low)OV-6(low)CD90(+) population emerged that lacked csVimentin and PD-L1 expression. Expression analyses showed that this new CSC subset shared similar pluripotency and EMT features with the already-known CSCs. FACS results further revealed that this subset is also generated from non-CSCs. In conclusion, we showed that hepatoblastoma CSCs express PD-L1 and that the biology of hepatoblastoma CSCs is of a plastic nature. Chemotherapeutic treatment leads to another CSC subset, which is highly chemoresistant and could be responsible for a poor prognosis after postoperative chemotherapy.
format Online
Article
Text
id pubmed-9736435
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97364352022-12-11 Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy Lee-Theilen, Mieun Fadini, Delaine D. Hadhoud, Julia R. van Dongen, Fleur Kroll, Gabriela Rolle, Udo Fiegel, Henning C. Cancers (Basel) Article SIMPLE SUMMARY: Cancer stem cells are thought to cause a poor response to chemotherapies. The aim of our study was to explore the still unknown biology of hepatoblastoma cancer stem cells that are essential for tumorigenesis. With our investigations, we aimed to gain more insight into cancer stem cell characteristics and to provide directions for new therapeutic approaches to treat refractory hepatoblastoma. We showed that hepatoblastoma cancer stem cells express PD-L1, a factor which helps tumors escape immune attacks. Furthermore, we detected cancer stem cell progeny evolving from non-cancer stem cells. Finally, we revealed that another subset of cancer stem cells is induced during chemotherapy. Our findings give a possible explanation why chemotherapies fail in certain hepatoblastoma cases and why new therapeutic approaches should consider the plasticity of hepatoblastoma cancer stem cells. ABSTRACT: The biology of cancer stem cells (CSCs) of pediatric cancers, such as hepatoblastoma, is sparsely explored. This is mainly due to the very immature nature of these tumors, which complicates the distinction of CSCs from the other tumor cells. Previously, we identified a CSC population in hepatoblastoma cell lines expressing the CSC markers CD34 and CD90, cell surface Vimentin (csVimentin) and binding of OV-6. In this study, we detected the co-expression of the immune escape factor PD-L1 in the CSC population, whereas the other tumor cells remained negative. FACS data revealed that non-CSCs give rise to CSCs, reflecting plasticity of CSCs and non-CSCs in hepatoblastoma as seen in other tumors. When we treated cells with cisplatin and decitabine, a new CD34(+/low)OV-6(low)CD90(+) population emerged that lacked csVimentin and PD-L1 expression. Expression analyses showed that this new CSC subset shared similar pluripotency and EMT features with the already-known CSCs. FACS results further revealed that this subset is also generated from non-CSCs. In conclusion, we showed that hepatoblastoma CSCs express PD-L1 and that the biology of hepatoblastoma CSCs is of a plastic nature. Chemotherapeutic treatment leads to another CSC subset, which is highly chemoresistant and could be responsible for a poor prognosis after postoperative chemotherapy. MDPI 2022-11-25 /pmc/articles/PMC9736435/ /pubmed/36497307 http://dx.doi.org/10.3390/cancers14235825 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lee-Theilen, Mieun
Fadini, Delaine D.
Hadhoud, Julia R.
van Dongen, Fleur
Kroll, Gabriela
Rolle, Udo
Fiegel, Henning C.
Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy
title Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy
title_full Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy
title_fullStr Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy
title_full_unstemmed Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy
title_short Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy
title_sort hepatoblastoma cancer stem cells express pd-l1, reveal plasticity and can emerge upon chemotherapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736435/
https://www.ncbi.nlm.nih.gov/pubmed/36497307
http://dx.doi.org/10.3390/cancers14235825
work_keys_str_mv AT leetheilenmieun hepatoblastomacancerstemcellsexpresspdl1revealplasticityandcanemergeuponchemotherapy
AT fadinidelained hepatoblastomacancerstemcellsexpresspdl1revealplasticityandcanemergeuponchemotherapy
AT hadhoudjuliar hepatoblastomacancerstemcellsexpresspdl1revealplasticityandcanemergeuponchemotherapy
AT vandongenfleur hepatoblastomacancerstemcellsexpresspdl1revealplasticityandcanemergeuponchemotherapy
AT krollgabriela hepatoblastomacancerstemcellsexpresspdl1revealplasticityandcanemergeuponchemotherapy
AT rolleudo hepatoblastomacancerstemcellsexpresspdl1revealplasticityandcanemergeuponchemotherapy
AT fiegelhenningc hepatoblastomacancerstemcellsexpresspdl1revealplasticityandcanemergeuponchemotherapy